Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer
Updated on: September 29,2025
0
Study: Iza-bren and osimertinib combination shows 100% response rate in EGFR-mutated lung cancer
Updated on:September 29,2025
0
